Status:

COMPLETED

Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study)

Lead Sponsor:

Ministry of Science and Higher Education, Poland

Conditions:

Coronary Artery Stenosis

Myocardial Revascularization

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Unprotected left main coronary artery (ULMCA) stenting, offering restoration of a native flow to left coronary artery, is the subject of intense investigations as a potential alternative to bypass sur...

Detailed Description

The natural history and the results of pharmacological treatment in patients with severe narrowing of left main coronary artery show very poor prognosis (5 year survival less than 50%). There is gene...

Eligibility Criteria

Inclusion

  • The patients' age 18 to 80
  • Significant LM stenosis (\>50%)
  • The target vessel reference diameter 2.5mm.
  • Concomitant multivessel disease suitable for PCI is allowed.
  • The patient is an acceptable candidate for coronary artery bypass surgery.
  • The patient agreement for 6 month follow-up cardiac catheterization, which will include left ventricular angiogram.
  • The patient written informed consent.

Exclusion

  • An allergy or contraindication to aspirin, ticlopidine or Clopidogrel.
  • Presence of diffuse, significant (\>++) calcifications in LM
  • Left ventricular ejection fraction \< 35%
  • History of bleeding diathesis or coagulopathy.
  • Any previous PCI or CABG surgery
  • Acute MI within 48 hours, cardiogenic shock.
  • Bail-out stenting of dissected LM during complicated PCI.
  • The patient suffered a stroke or transient ischemic neurological attack (TIA) within 3 months.
  • Chronic renal insufficiency.
  • Positive pregnancy test.
  • Any disease that may shorten the life expectancy of the patient.
  • The patient is currently participating in another research study.

Key Trial Info

Start Date :

January 1 2001

Trial Type :

INTERVENTIONAL

End Date :

December 1 2005

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT00375063

Start Date

January 1 2001

End Date

December 1 2005

Last Update

September 12 2006

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital, Bryn Mawr, PA, USA and Thomas Jefferson University, Philadelphia

Bryn Mawr, Pennsylvania, United States, 19010

2

San Antonio Endovascular and Heart Institute and University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78248

3

Jagiellonian University

Krakow, Lesser Poland Voivodeship, Poland, 31-147

4

Silesian Medical School 1-st Department of Cardiosurgery

Katowice, Silesian Voivodeship, Poland, 40-635